|
ºÐ´ç¼¿ï´ëÇб³º´¿øÀº ¿À´Â 18ÀÏ ¿ÀÀü 9½ÃºÎÅÍ ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ©¿¡¼ ‘Á¦2ȸ ´ëÀå¾Ï ´ÙÇÐÁ¦Áø·á(Multi-Disciplinary Treatment) ½ÉÆ÷Áö¾ö’À» °³ÃÖÇÑ´Ù.
À۳⿡ ÀÌ¾î ¿ÃÇØ 2ȸ°¸¦ ¸ÂÀÌÇÑ À̹ø ½ÉÆ÷Áö¾öÀº ±¹³» ÃÖ°íº´¿ø ´ëÀå¾Ï ÀÇ·áÁøÀ» ºñ·ÔÇØ ¸ðµç °ú°¡ Âü¿©ÇØ °¢ ¿µ¿ª¿¡¼ ´ëÀå¾Ï Ä¡·á¸¦ À§ÇÑ ´ÙÇÐÁ¦Áø·á(MDT) ¹æ¹ýÀ» ¸ð»öÇϰí ȯÀÚÀÇ Æ¯¼º¿¡ µû¸¥ ¹Ù¶÷Á÷ÇÑ Ä¡·á ¹æ¾ÈÀ» ³íÀÇÇϱâ À§ÇØ ¸¶·ÃµÆ´Ù.
´Ù¼¸ °³ ¼¼¼ÇÀ¸·Î ³ª´² ÁøÇàµÉ À̹ø ½ÉÆ÷Áö¾öÀº ¡ãÁ÷Àå¾Ï Ä¡·áÀÇ ³Á¦ ¹× Çõ½Å ¹æ¾È(Rectal Cancer-Big Questions and Innovation) ¡ãÁ÷Àå¾Ï Ç׾Ϲæ»ç¼±¿ä¹ý ÈÄ ÁÁÀº ¹ÝÀÀÀ» º¸ÀΠȯÀÚ¸¦ À§ÇÑ Àü·«(Strategy for good responder after chemoradiotherapy for rectal cancer) ¡ãÁ÷Àå¾Ï Ä¡·á ÈÄ °¨½Ãü°èÀÇ ±Ù°Å¿Í ÇѰèÁ¡(Surveillance of rectal cancer: Evidence & Limitations) ¡ãÀýÁ¦ ºÒ°¡´ÉÇÑ ÀüÀÌ/Àç¹ß ´ëÀå¾Ï Ä¡·á(Management of non-resectable metastatic or recurrent colorectal cancer) ¡ã´ëÀå¾Ï ¹ÌÁ¦¿Í Á¦¾ð(Unsolved issues and suggestion) ¼øÀ¸·Î ÁøÇàµÇ¸ç, °¢ ÁÖÁ¦¿¡ ¸Â´Â °¿¬°ú ÆÐ³Î ÅäÀǸ¦ ÅëÇØ ´ëÀå¾Ï ȯÀÚ Ä¡·á¿¡ ´ëÇÑ ¹ßÀüµÈ ³íÀǰ¡ ÆîÃÄÁú ¿¹Á¤ÀÌ´Ù.
À̹ø ½ÉÆ÷Áö¾öÀ» ÁÖ°üÇÏ´Â ºÐ´ç¼¿ï´ëº´¿ø ´ëÀå¾Ï¼¾ÅÍÀå °¼º¹ü ±³¼ö´Â “À̹ø ½ÉÆ÷Áö¾öÀ» ÅëÇØ ±¸Ã¼ÀûÀÎ ÀÓ»ó ÇöÀå¿¡¼ À¯ÀÏÇϰí Çϳª»ÓÀΠȯÀÚ¿¡°Ô ÃÖ»óÀÇ Æ¯º°ÇÑ Ä¡·á¸¦ ½ÃÇàÇÒ ¼ö ÀÖ´Â ¹ÙÅÁÀ» ¾òÀ» ¼ö ÀÖ´Â ¶æ ±íÀº ÀÚ¸®°¡ µÇ±æ ¹Ù¶õ´Ù”°í ¸»Çß´Ù. |